Presepsin as a novel diagnostic biomarker for differentiating active pulmonary tuberculosis from bacterial community acquired pneumonia

Woodhead, 2011, Guidelines for the management of adult lower respiratory tract infections–full version, Clin. Microbiol. Infect., 17, E1, 10.1111/j.1469-0691.2011.03672.x Mandell, 2007, Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults, Clin. Infect. Dis., 44, S27, 10.1086/511159 El Khéchine, 2011, Diagnosis of pulmonary tuberculosis in a microbiological laboratory, Med. Mal. Infect., 41, 509, 10.1016/j.medmal.2011.07.012 Parrish, 2011, Role of the clinical mycobacteriology laboratory in diagnosis and management of tuberculosis in low-prevalence settings, J. Clin. Microbiol., 49, 772, 10.1128/JCM.02451-10 Chenevier-Gobeaux, 2015, Presepsin (sCD14-ST), an innate immune response marker in sepsis, Clin. Chim. Acta, 450, 97, 10.1016/j.cca.2015.06.026 Klouche, 2016, Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients, Ann. Intensive Care, 6, 59, 10.1186/s13613-016-0160-6 Liu, 2014, Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department, Respir. Med., 108, 1204, 10.1016/j.rmed.2014.05.005 Klouche, 2016, Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquiredpneumonia in ICU patients, Ann. Intensive Care, 6, 59, 10.1186/s13613-016-0160-6 Masson, 2015, Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial, Intensive Care Med., 41, 12, 10.1007/s00134-014-3514-2 Matera, 2017, Soluble CD14 subtype-a new biomarker in predicting the outcome of critically ill septic patients, Am J Med Sci, 353, 543, 10.1016/j.amjms.2017.03.036 Zanoni, 2013, Role of CD14 in host protection against infections and in metabolism regulation, Front. Cell. Infect. Microbiol., 3, 32, 10.3389/fcimb.2013.00032 Eurosurveillance editorial team, 2013, WHO publishes Global tuberculosis report 2013, Euro. Surveill., 18 Cao, 2017, Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association, Clin. Respir. J. Sharp, 2016, CURB-65 performance among admitted and discharged emergency department patients with community-acquired pneumonia, Acad. Emerg. Med., 23, 400, 10.1111/acem.12929 Sia, 2015, Innate immune defenses in human tuberculosis: an overview of the interactions between Mycobacterium tuberculosis and innate immune cells, J Immunol Res, 2015, 747543, 10.1155/2015/747543 Yaegashi, 2005, Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis, J. Infect. Chemother., 11, 234, 10.1007/s10156-005-0400-4 Feruglio, 2013, Soluble markers of the toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses, PLoS One, 8, 10.1371/journal.pone.0069896 Alavi-Naini, 2012, Association between the CD14 gene C-159T polymorphism and serum soluble CD14 with pulmonary tuberculosis, Int. J. Tuberc. Lung Dis., 16, 1383, 10.5588/ijtld.11.0827 Juffermans, 1998, Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis, J. Infect. Dis., 178, 1839, 10.1086/314492 Kim, 2017, Bacteremia prediction model for community-acquired pneumonia: external validation in a multicenter retrospective cohort, Acad. Emerg. Med., 10.1111/acem.13255 Afshar, 2009, Blood cultures for community-acquired pneumonia: are they worthy of two quality measures? A systematic review, J. Hosp. Med., 4, 112, 10.1002/jhm.382 Anevlavis, 2009, A prospective study of the diagnostic utility of sputum Gram stain in pneumonia, J. Inf. Secur., 59, 83 Fukuyama, 2014, Validation of sputum Gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study, BMC, Infect. Dis., 14, 534